These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8997937)

  • 1. Validation of client decision-making instruments in the context of psychiatry.
    Bunn H; O'Connor A
    Can J Nurs Res; 1996; 28(3):13-27. PubMed ID: 8997937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of the Decisional Conflict Scale for measuring the quality of end-of-life decision making.
    Song MK; Sereika SM
    Patient Educ Couns; 2006 Jun; 61(3):397-404. PubMed ID: 15970420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the psychometric properties of the Calgary Depression Scale for Schizophrenics (CDSS) in a Hungarian clinical population of patients with schizophrenia].
    Nagy J; Bitter I
    Neuropsychopharmacol Hung; 2011 Mar; 13(1):33-40. PubMed ID: 21451190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Self-rating scales in schizophrenia: validity assessment of the Paranoid-Depression Scale (PD-S), the Frankfurt Self-feeling Scale (FBS) and of two visual analogy scales].
    Schaeffer E; Wciórka J
    Psychiatr Pol; 2003; 37(2):293-314. PubMed ID: 12776660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do baseline client characteristics predict the therapeutic alliance in the treatment of schizophrenia?
    Couture SM; Roberts DL; Penn DL; Cather C; Otto MW; Goff D
    J Nerv Ment Dis; 2006 Jan; 194(1):10-4. PubMed ID: 16462549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Self-rating scales in schizophrenia: assessment of the practical applicability of the Paranoid-Depression Scale (PD-S), the Frankfurt Self-feeling Scale (FBS) and of two visual analogue scales].
    Schaeffer E; Wciórka J
    Psychiatr Pol; 2003; 37(2):315-35. PubMed ID: 12776661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlates of treatment-related decision-making capacity among middle-aged and older patients with schizophrenia.
    Palmer BW; Dunn LB; Appelbaum PS; Jeste DV
    Arch Gen Psychiatry; 2004 Mar; 61(3):230-6. PubMed ID: 14993110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Calgary Depression Rating Scale for schizophrenia in a healthy control group: psychometric properties and reference values.
    Müller MJ; Brening H; Gensch C; Klinga J; Kienzle B; Müller KM
    J Affect Disord; 2005 Sep; 88(1):69-74. PubMed ID: 16040126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stabilization of the internal structure of persistent auditory verbal hallucinations in schizophrenia.
    Chang JS; Yi JS; Ahn YM; Kim JH; Kim YS
    Aust N Z J Psychiatry; 2009 Mar; 43(3):244-51. PubMed ID: 19221913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Insight in schizophrenia: assessment of 31 patients with different scales].
    Travers D; Levoyer D; Millet B
    Encephale; 2008 Jan; 34(1):66-72. PubMed ID: 18514153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 4-Point ordinal Alliance Self-report: a self-report questionnaire for assessing therapeutic relationships in routine mental health.
    Misdrahi D; Verdoux H; Lançon C; Bayle F
    Compr Psychiatry; 2009; 50(2):181-5. PubMed ID: 19216896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Validation of the Temporal Experience of Pleasure Scale (TEPS) in a French-speaking environment].
    Favrod J; Ernst F; Giuliani F; Bonsack C
    Encephale; 2009 Jun; 35(3):241-8. PubMed ID: 19540410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of insight in patients with bipolar disorder: are self-rated scales developed for patients with schizophrenia applicable?
    Jónsdóttir H; Engh JA; Friis S; Birkenaes A; Ringen PA; Vaskinn A; Sundet K; Opjordsmoen S; Andreassen OA
    J Nerv Ment Dis; 2008 Apr; 196(4):333-5. PubMed ID: 18414129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
    Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M
    J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychometric properties of the Treatment Decision Evaluation Scale in patients with cancer in Turkey.
    Erci B; Ozdemir S
    Eur J Oncol Nurs; 2008 Dec; 12(5):464-8. PubMed ID: 18845477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construct and discriminant validity and dimensionality of the Interview Schedule for Social Interaction (ISSI) in three psychiatric samples.
    Eklund M; Bengtsson-Tops A; Lindstedt H
    Nord J Psychiatry; 2007; 61(3):182-8. PubMed ID: 17523029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The decisional conflict scale: moving from the individual to the dyad level.
    Légaré F; Leblanc A; Robitaille H; Turcotte S
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(4):247-52. PubMed ID: 22749071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new brief instrument for assessing decisional capacity for clinical research.
    Jeste DV; Palmer BW; Appelbaum PS; Golshan S; Glorioso D; Dunn LB; Kim K; Meeks T; Kraemer HC
    Arch Gen Psychiatry; 2007 Aug; 64(8):966-74. PubMed ID: 17679641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of the zung self-rating depression scale for schizophrenics.
    Kaneda Y
    J Med Invest; 1999 Feb; 46(1-2):75-8. PubMed ID: 10408161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Psychometric properties of PANSS (Positive and Negative Syndrome Scale) in the French version in a sample of schizophrenic patients].
    Lançon C; Auquier P; Llorca PM; Martinez JL; Bougerol T; Scotto JC
    Encephale; 1997; 23(1):1-9. PubMed ID: 9172961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.